EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | | | --- | --- | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | | | 股票發行人現金股息公告 | | | | | 發行人名稱 | 宏利金融有限公司 | | | | 股份代號 | 00945 | | | | 多櫃檯股份代號及貨幣 | 不適用 | | | | 相關股份代號及名稱 | 不適用 | | | | 公告標題 | 宏利宣布派發普通股股息 | | | | 公告日期 | 2026年2月11日 | | | | 公告狀態 | 新公告 | | | | 股息信息 | | | | | 股息類型 | 第四季度 | | | | 股息性質 | 普通股息 | | | | 財政年末 | 2025年12月31日 | | | | 宣派股息的報告期末 | 2025年12月31日 | | | | 宣派股息 | 每 股 0.485 CAD | | | | 股東批准日期 | 不適用 | | | ...

新聞稿 宏利金融有限公司是全球領先的金融服務供應商，致力於幫助大眾輕鬆作出明智抉擇，實現精彩 人生。本公司為個人、團體及企業提供理財建議及保險方案，全球總部設於加拿大多倫多，在加 拿大、亞洲及歐洲以「宏利」名稱營運，而在美國主要以「恒康」名稱經營業務。通過「宏利財 富與資產管理」，我們為全球個人客戶、機構客戶及退休計劃成員，提供投資、理財建議及退休計 劃服務。截至 2024 年底，本公司有超過 37,000 員工、超過 109,000 代理人，以及數以萬計的經 銷合作夥伴，為逾 3,600 萬客戶提供服務。本公司在多倫多、紐約及菲律賓證券交易所以股份代 號 MFC 上市，並在香港交易所以股份代號 945 上市。 並非所有產品及服務均在所有司法管轄區提供。詳情請瀏覽 manulife.com。 Fiona McLean Derek Theobalds Manulife Manulife 437-441-7491 416-254-1774 除非另有註明，所有金額均按加元呈列 TSX/NYSE/PSE: MFC SEHK: 945 即時發佈 2026 年 2 月 11 日 宏利將普通股股息上調 10.2% 多倫多 ...

TSX/NYSE/PSE: MFC SEHK: 945 除非另有註明，所有金額均按加元呈列 宏利公佈 2025 年全年及第四季業績 多倫多 – 2026 年 2 月 11 日 – 宏利金融有限公司（「宏利」或「本公司」）宣佈截至 2025 年 12 月 31 日的全年及 第四季業績，全年核心盈利及保險新造業務表現 1均創下新高，並宣佈普通股股息上調 10.2%。 2025 年全年及第四季業績的主要重點包括： 「2025 年對宏利而言是具有重要意義的一年。我們的核心盈利創下新高，完成多項具針對性的策略投資，並推 出了優化企業策略。在所有保險業務板塊中，我們均錄得超過 20% 的新造業務 CSM 增長，帶動 CSM 餘額錄 得雙位數升幅，為未來的盈利貢獻奠定了穩固基礎。通過審慎的資本部署，我們進一步強化多元化業務佈局，包 括收購 Comvest Credit Partners，宣佈與 Mahindra 合作成立合資企業進軍印度人壽保險市場 9，在迪拜國際金 融中心設立高淨值客戶辦事處，以及達成收購施羅德印尼的協議 10。這些舉措擴充了我們為客戶提供的世界級投 資及保險方案。此外，Evident AI 將宏利評為 ...

Core Viewpoint - Manulife Financial Corporation has filed its 2025 audited annual financial statements and related Management's Discussion and Analysis (MD&A) with securities regulators, indicating compliance with regulatory requirements and transparency in financial reporting [1] Group 1 - The financial statements pertain to the year ended December 31, 2025, showcasing the company's financial performance for that period [1] - The filings have been made with both the Canadian Securities Administrators and the U.S. Securities and Exchange Commission on Form 40-F, highlighting the company's cross-border regulatory compliance [1] - The information is accessible on the company's website, providing investors with easy access to financial results and reports [1]

Financial Performance - Core earnings for 2025 totaled $7,521 million, up from $7,182 million in 2024, reflecting a year-over-year increase of 4.7%[53] - The net income attributed to shareholders for 2025 was $5,572 million, compared to $5,385 million in 2024, marking a 3.5% increase[53] - The company reported a restructuring charge of $12 million in Q4 2025, down from $52 million in Q4 2024[53] - Core earnings (post-tax) for 2024 totaled $7,182 million, with contributions from Asia ($2,466 million), Canada ($1,568 million), U.S. ($1,690 million), and Global WAM ($1,673 million) while Corporate and Other reported a loss of $(215) million[67] - The net income attributed to shareholders (post-tax) for 2024 was $5,385 million, after excluding items from core earnings[66] - In 4Q25, core earnings (post-tax) reached $1,993 million, with Asia contributing $785 million, Canada $413 million, U.S. $319 million, and Global WAM $490 million[70] - The net income attributed to shareholders (post-tax) in 4Q25 was $1,499 million, reflecting a strong performance across segments despite market experience losses[69] - The company experienced market experience losses of $(1,450) million in 2024, significantly impacting net income attributed to shareholders[66] - Core earnings for Q4 2024 totaled $1,907 million, a decrease from $1,806 million in Q4 2023[79] - Net income attributed to shareholders for Q4 2024 was $1,638 million, compared to $1,707 million in the previous quarter[77] Core Earnings and Revenue - Core earnings (pre-tax) for 2024 amounted to $8,492 million, with significant contributions from all regions, particularly the U.S. segment[67] - The company reported a core earnings (post-tax) adjustment of $86 million on a CER basis for 2024, indicating a positive impact from foreign exchange rates[67] - The core earnings (post-tax) for the U.S. segment in 4Q25 were $319 million, reflecting ongoing operational challenges[70] - The company reported a core ROE of 16.5% for the full year 2024, slightly up from 16.2% in 2023[83] - The company’s core earnings (pre-tax) for Q4 2024 were $2,252 million, indicating a robust operational performance despite market challenges[79] - Core earnings for 2025 were reported at $2,571 million, an increase from $2,173 million in 2024, reflecting a growth of 18.3%[92] - Core revenue for Q4 2025 reached $2,285 million, a 6.8% increase from Q4 2024's $2,140 million[93] - Global WAM core revenue for 2025 totaled $8,669 million, an increase of 8.1% compared to $8,016 million in 2024[93] Investment and Assets - Average assets under management (AUM) for 2025 were reported at $1,932 million, an increase from $1,673 million in 2024[53] - Total investment income for 2025 was $25,289 million, up from $20,459 million in 2024, reflecting a significant growth of 23.5%[93] - Investment income in Global WAM for Q4 2025 was $164 million, compared to $78 million in Q4 2024, marking a 110.3% increase[93] - The company reported a total other revenue and investment income in Global WAM of $2,283 million for Q4 2025, up from $2,083 million in Q4 2024[93] - Adjusted book value as of December 31, 2025, was $64,194 million, an increase from $62,665 million as of December 31, 2024[91] Market and Business Development - The Global Minimum Tax (GMT) was enacted retroactively to fiscal periods starting December 31, 2023, impacting both core earnings and items excluded from core earnings[55] - The reinsurance transaction with the Reinsurance Group of America closed on January 1, 2025, contributing to the overall financial strategy[53] - The Evident AI Index for Insurance ranked the company among the top 30 insurance firms in North America and Europe, indicating strong performance in talent, innovation, leadership, and transparency[11] - The company anticipates continued benefits from AI utilization and potential common share repurchases in the future[95] - The company is focused on executing strategic plans, including market expansion and digital transformation initiatives[97] - The company is actively pursuing regulatory approvals for entering new markets, including the Indian insurance market[97] New Business Metrics - Total new business CSM for 4Q25 reached $1,020 million, a 5.6% increase from $966 million in 3Q25[87] - Asia's new business CSM totaled $697 million in 4Q25, compared to $712 million in 3Q25, reflecting a decrease of 2.1%[87] - The U.S. market contributed $188 million to new business CSM in 4Q25, up from $145 million in 3Q25, marking a growth of 29.7%[87] - New business CSM in Hong Kong for 4Q25 was $244 million, down from $287 million in 3Q25, a decline of 15%[87] - Net income attributed to shareholders for Asia in 4Q25 was $623 million, up from $583 million in 4Q24, representing a year-over-year increase of 6.9%[89] - The net income attributed to shareholders in Canada for 4Q25 was $252 million, down from $439 million in 4Q24, a decrease of 42.5%[89]

Core Viewpoint - Manulife Financial Corporation has announced a 10.2% increase in its quarterly common shareholders' dividend, raising it to $0.485 per share, effective March 19, 2026 [1]. Group 1: Dividend Announcement - The Board of Directors declared a dividend increase of 4.5 cents per share, resulting in a new dividend of $0.485 per share [1]. - The dividend is payable to shareholders of record as of February 25, 2026 [1]. - The company will purchase common shares on the open market for its Canadian and U.S. Dividend Reinvestment and Share Purchase Plans, with no applicable discounts on the purchase price [1]. Group 2: Company Overview - Manulife is a leading international financial services provider, operating under the name Manulife in Canada, Asia, and Europe, and as John Hancock in the United States [1]. - The company offers financial advice, insurance, and investment services, serving over 36 million customers globally [1]. - As of the end of 2024, Manulife had more than 37,000 employees and over 109,000 agents [1].

Core Insights - Manulife Financial Corporation reported record core earnings and insurance new business results for the year 2025, with a 10.2% increase in common share dividends [1][2] - The company announced a new Normal Course Issuer Bid program to repurchase up to 2.5% of outstanding common shares, expected to commence in late February 2026 [1][2] - The company achieved over 20% growth in new business CSM across all insurance segments, contributing to double-digit growth in CSM balance [1][3] Financial Performance - Core earnings for 2025 reached $7.5 billion, a 3% increase from 2024, with 4Q25 core earnings at $2.0 billion, up 5% year-over-year [3][4] - Net income attributed to shareholders for 2025 was $5.6 billion, a $0.2 billion increase compared to 2024, while 4Q25 net income was $1.5 billion, down $0.1 billion from 4Q24 [3][4] - The company reported a core EBITDA margin improvement of 260 basis points in Global WAM [1][2] Business Segments Performance - In Asia, net income attributed to shareholders increased by 22% to $2.1 billion, with core earnings up 18% [3][4] - Canada saw a net income decrease of 43% to $1.3 billion, while core earnings increased by 6% [3][4] - The U.S. segment reported a net income loss of $367 million, with core earnings down 22% [3][4] Strategic Initiatives - Manulife entered the Indian life insurance market through a joint venture with Mahindra, expanding its global footprint [1][2] - The company acquired 75% of Comvest Credit Partners, enhancing its private credit capabilities [2][3] - A new simplified lending suite was launched in Canada to streamline the lending experience for high-net-worth clients [2][3] Customer Engagement and Innovation - The company launched the Manulife Longevity Institute, investing $350 million through 2030 to promote healthier and financially secure lives [2][3] - Manulife deployed GenAI sales enablement solutions across multiple markets, enhancing client interactions and sales performance [2][3] - A strategic collaboration with Bupa International Limited was established to enhance healthcare access for customers in Hong Kong [2][3] Market Trends and Challenges - Global WAM experienced net outflows of $14.3 billion in 2025, compared to net inflows of $13.3 billion in 2024, driven by lower net sales through third-party intermediaries [4][5] - The company faced challenges in the U.S. segment due to unfavorable life insurance claims experience and lower investment spreads [3][4] - Despite macroeconomic uncertainties, the company remains focused on disciplined execution and sustainable growth [1][2]

Core Viewpoint - Manulife Financial Corporation intends to launch a Normal Course Issuer Bid (NCIB) to purchase up to 42 million common shares, approximately 2.5% of its outstanding shares, as part of its capital management strategy to enhance shareholder value [1]. Group 1: NCIB Details - The NCIB is subject to approval from the Toronto Stock Exchange (TSX) and has already received approval from the Office of the Superintendent of Financial Institutions (Canada) [1]. - As of January 31, 2026, Manulife had 1,676,743,043 common shares issued and outstanding [1]. - The bid period will commence after TSX acceptance and will last for up to one year, with all shares acquired under the NCIB to be cancelled [1]. Group 2: Purchase Mechanisms - Purchases may occur through TSX, New York Stock Exchange, and alternative trading systems at market prices or other permitted prices [1]. - Manulife may also acquire shares outside Canada and the U.S. and enter into derivative-based programs to support its purchase activities, subject to regulatory approval [1]. - The total number of shares purchased under the NCIB and other arrangements will not exceed 42 million [1]. Group 3: Previous NCIB Performance - Manulife's previous NCIB (2025 NCIB) commenced on February 24, 2025, allowing for the purchase of up to 51.5 million common shares, which was completed by January 22, 2026, at an average purchase price of $44.28 per share [1].

Core Viewpoint - The Hong Kong insurance stocks experienced a collective surge, with major companies like China Life and Ping An rising over 5%, driven by favorable market conditions and strategic positioning in the insurance sector [1] Group 1: Market Performance - China Life's stock price increased by 5.22% to 35.460 [2] - Ping An's stock price rose by 5.03% to 73.100 [2] - China Taiping's stock price went up by 4.79% to 25.820 [2] - China Pacific's stock price increased by 4.46% to 40.260 [2] - Other notable increases include China People's Insurance at 3.50%, New China Life at 3.39%, and China Property & Casualty at 3.22% [2] Group 2: Industry Insights - CITIC Securities' report indicates that with a large number of deposits maturing, savings-type insurance products are expected to meet the demand for stable long-term value growth due to their high returns and long terms [1] - The report anticipates that leading insurance companies will capitalize on improved bancassurance value rates, leading to rapid growth in new policies and new business value (NBV) [1] - The asset side is expected to benefit from a spring rally in the equity market, enhancing profits, while stable interest rates will support long-term returns for insurance funds [1] Group 3: Future Projections - Huaxi Research predicts that listed insurance companies will continue to see rapid growth in net profit attributable to shareholders through 2025, although Q4 may face some pressure from investment impacts [1] - The report highlights a high level of enthusiasm for the insurance sector in Q1 2026, driven by the "opening red" period and the transformation of savings-type insurance products, which will alleviate pressure from interest rate spreads [1] - Recommended stocks include Ping An for its improved fundamentals and high dividend yield, New China Life for its asset flexibility and high dividend yield, and China Life for its asset flexibility [1]

Core Viewpoint - The Hong Kong insurance stocks have collectively risen, with major companies like China Life and Ping An increasing by over 5%, driven by favorable market conditions and growth in new business value (NBV) [1] Group 1: Market Performance - China Life's stock price increased by 5.22% to 35.460 [2] - Ping An's stock price rose by 5.03% to 73.100 [2] - China Taiping's stock price went up by 4.79% to 25.820 [2] - China Pacific's stock price increased by 4.46% to 40.260 [2] - Other companies like China People’s Insurance and New China Life also saw increases of over 3% [1] Group 2: Industry Insights - CITIC Securities' report indicates that with a large amount of deposits maturing, savings-type insurance products are expected to meet the demand for stable long-term value growth due to their high returns and long terms [1] - The leading insurance companies are expected to leverage the improvement in bancassurance value rates to enhance their market positioning, leading to rapid growth in new business and NBV [1] - The asset side is anticipated to benefit from a bullish equity market in spring, which will enhance profits, while stable interest rates will support long-term returns for insurance funds [1] Group 3: Future Projections - Huaxi Research forecasts that the net profit attributable to shareholders of listed insurance companies will continue to grow rapidly through 2025, although Q4 may face some pressure from investment impacts [1] - The high demand for new business value in Q1 2026 is expected to significantly increase year-on-year, driven by the favorable conditions at the beginning of the year [1] - The transformation towards dividend insurance is expected to alleviate pressure from interest rate spreads, further driving the valuation recovery of insurance stocks [1] Group 4: Stock Recommendations - Recommended stocks include Ping An for its improving fundamentals and high dividend yield, New China Life for its asset flexibility and high dividend yield, and China Life for its asset flexibility [1] - Other recommended stocks include China People’s Insurance and China Pacific for their stable performance, as well as ZhongAn Online for its business improvements [1]